Jennifer Esq - Galera Therapeutics Chief Secretary

Executive

Jennifer Esq is Chief Secretary of Galera Therapeutics
Age 59
Phone610 725 1500
Webhttps://www.galeratx.com

Galera Therapeutics Management Efficiency

The company has return on total asset (ROA) of (0.5929) % which means that it has lost $0.5929 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (10.6311) %, meaning that it created substantial loss on money invested by shareholders. Galera Therapeutics' management efficiency ratios could be used to measure how well Galera Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.
Galera Therapeutics currently holds 152.3 M in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Galera Therapeutics has a current ratio of 4.92, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Galera Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Galera Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Galera Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Galera to invest in growth at high rates of return. When we think about Galera Therapeutics' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

Robert ArbeitX4 Pharmaceuticals
77
Andrew GengosTerns Pharmaceuticals
61
Adam JDDay One Biopharmaceuticals
58
Lars MBAPDS Biotechnology Corp
55
John StubenrauchDay One Biopharmaceuticals
N/A
Sanjay ZaveriPDS Biotechnology Corp
N/A
Soojin KimInozyme Pharma
N/A
Debra SieminskiTerns Pharmaceuticals
N/A
Prof MDDay One Biopharmaceuticals
55
Elly MDDay One Biopharmaceuticals
N/A
JD EsqTerns Pharmaceuticals
56
Pharm MPHX4 Pharmaceuticals
N/A
Jeffrey JasperTerns Pharmaceuticals
N/A
Linda ArsenaultAmylyx Pharmaceuticals
N/A
Kirk MDPDS Biotechnology Corp
73
FASCP MDInozyme Pharma
70
Pamela DanagherTerns Pharmaceuticals
N/A
James KanterTerns Pharmaceuticals
N/A
Deanne RandolphPDS Biotechnology Corp
N/A
Diana ChungTerns Pharmaceuticals
N/A
JD EsqAcumen Pharmaceuticals
54
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania. Galera Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 30 people. Galera Therapeutics [GRTX] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). Galera Therapeutics is listed under Pharmaceutical Products category by Fama And French industry classification.

Management Performance

Galera Therapeutics Leadership Team

Elected by the shareholders, the Galera Therapeutics' board of directors comprises two types of representatives: Galera Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Galera. The board's role is to monitor Galera Therapeutics' management team and ensure that shareholders' interests are well served. Galera Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Galera Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
Mel MD, President CEO
Dr MBA, CoFounder COO
Jennifer Esq, Chief Secretary
Andie Collier, Chief Officer
FACS FACS, Chief Officer
Christopher Degnan, Chief Officer
PharmD MBA, Chief Officer
Jon MD, Ex Officer
Dennis Riley, Emeritus Officer
Judy Schnyder, Senior Management

Galera Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Galera Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Consideration for investing in Galera Pink Sheet

If you are still planning to invest in Galera Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Galera Therapeutics' history and understand the potential risks before investing.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Global Correlations
Find global opportunities by holding instruments from different markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges